IRIS UniCatt

Torti, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.226
AS - Asia 1.186
EU - Europa 828
SA - Sud America 355
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.630
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.166
SG - Singapore 532
CN - Cina 290
BR - Brasile 288
DE - Germania 161
SE - Svezia 131
VN - Vietnam 118
IT - Italia 108
FR - Francia 93
UA - Ucraina 66
GB - Regno Unito 57
PL - Polonia 54
IE - Irlanda 43
IN - India 43
BD - Bangladesh 38
FI - Finlandia 36
ID - Indonesia 33
AR - Argentina 31
HK - Hong Kong 25
MX - Messico 24
CA - Canada 23
JP - Giappone 23
RU - Federazione Russa 21
KR - Corea 19
EC - Ecuador 15
NL - Olanda 14
ZA - Sudafrica 14
IQ - Iraq 13
TR - Turchia 12
AT - Austria 10
ES - Italia 6
LT - Lituania 6
UZ - Uzbekistan 6
BE - Belgio 5
CO - Colombia 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
KE - Kenya 4
MA - Marocco 4
PH - Filippine 4
PK - Pakistan 4
UY - Uruguay 4
VE - Venezuela 4
CH - Svizzera 3
CL - Cile 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
RO - Romania 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GN - Guinea 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
ME - Montenegro 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.630
Salva come PNG Salva come JPEG
Città #
Singapore 245
Chandler 162
Ashburn 129
Houston 74
Hefei 66
Beijing 53
New York 46
Redmond 45
Dublin 43
Kraków 42
Ho Chi Minh City 39
Hanoi 35
Jacksonville 32
San Mateo 31
São Paulo 31
Los Angeles 30
Jakarta 28
Boston 26
Cattolica 23
Hong Kong 23
Milan 23
Seoul 19
Wilmington 19
Kent 18
The Dalles 18
Nanjing 17
Rome 17
Tokyo 17
Frankfurt am Main 16
Brooklyn 13
Dallas 13
Seattle 13
Dearborn 12
Helsinki 12
Lawrence 12
Princeton 12
Buffalo 11
Nanchang 11
Chennai 10
Munich 10
Rio de Janeiro 10
Roubaix 10
Santa Clara 10
Chicago 9
Marseille 9
Poplar 9
Stockholm 9
Düsseldorf 8
Guayaquil 8
Haiphong 8
Mexico City 8
Moscow 8
Norwalk 8
Redwood City 8
San Jose 8
Warsaw 8
Belo Horizonte 7
Bexley 7
Lappeenranta 7
Montreal 7
Phoenix 7
Pune 7
Amsterdam 6
Ann Arbor 6
Hải Dương 6
Johannesburg 6
Mumbai 6
Nuremberg 6
Paris 6
Woodbridge 6
Ankara 5
Atlanta 5
Boardman 5
Brasília 5
Bremen 5
Brussels 5
Curitiba 5
Denver 5
Manaus 5
Monza 5
Portsmouth 5
Tashkent 5
Albuquerque 4
Dhaka 4
Hyderabad 4
London 4
Montevideo 4
Nürnberg 4
Orem 4
Ottawa 4
Quito 4
Rotonda 4
San Francisco 4
Tavagnacco 4
Tianjin 4
Turku 4
Vancouver 4
Vienna 4
Washington 4
Basra 3
Totale 1.855
Salva come PNG Salva come JPEG
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 249
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 162
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort) 139
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 132
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 118
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 117
Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe 116
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons 116
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 112
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 112
Liver fibrosis progression and clinical outcomes are intertwined: Role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCVcoinfected patients with detectable HCV-RNA A MASTER cohort study 109
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 103
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 85
Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from Italy 81
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 77
A systematic review of dalbavancin efficacy as a sequential therapy for infective endocarditis 76
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors 75
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy 73
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience 71
Survival in HIV-infected patients after a cancer diagnosis in the cART era: Results of an Italian multicenter study 71
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): Protocol for an open-label, randomised controlled trial 70
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 69
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational Study 68
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response 67
Prolonged survival in HIV-associated Progressive Multifocal Leukoencephalopathy treated with Pembrolizumab: a case series on treatment and long-term follow-up 66
Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received 66
The effect of primary drug resistance on CD4 cell decline and the viral load set-point in HIV positive individuals before the start of antiretroviral therapy 66
Heteroresistance and clinical outcomes: knowledge gaps 64
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice 63
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 61
HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir 61
Autochthonous dengue outbreak in Rome, Italy, in 2023 60
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 57
Treatment with valacyclovir during pregnancy for prevention of congenital cytomegalovirus infection: a real-life multicenter Italian observational study 56
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 55
Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort 55
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure 52
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study 49
New advances in management and treatment of cardiac implantable electronic devices infections 49
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19 48
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 48
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 47
Assessing dengue seroprevalence among people living with HIV (PLWH) in rome, Italy: Insights from the 2023 Italian autochthonous outbreak 43
Evolving phenotypes of non-hospitalized patients that indicate long COVID 42
Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis 41
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask 39
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 29
Totale 3.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.279
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 9 9 4 20 2 14 2
2021/2022164 6 9 1 6 7 4 11 30 7 7 36 40
2022/2023413 62 61 31 48 36 50 13 36 50 4 13 9
2023/2024219 10 54 1 15 4 39 13 11 3 4 42 23
2024/2025755 5 10 47 9 38 19 51 35 70 72 205 194
2025/20261.497 357 119 220 409 367 25 0 0 0 0 0 0
Totale 3.685